Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsZhiqiang Ku, Zhiqiang An, Dean Ng et al.|Nature|2021Cited by 186
P815: HIGH VALENCY OF IGM-2644, A CD38XCD3 IGM BISPECIFIC T CELL ENGAGER, DISPLACES DARATUMUMAB BINDING AND INDUCES POTENT MULTIPLE MYELOMA CELL KILLINGKevin C. Hart, Maya F. Kotturi, Daniel Santos et al.|HemaSphere|2023Cited by 0
Author Correction: Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variantsZhiqiang Ku, Zhiqiang An, Xuping Xie et al.|Nature|2025Cited by 0